By stimulating insulin release and inhibiting glucagon, Tirzepatide helps stabilize blood sugar levels, reducing the risk of hyperglycemia, insulin resistance, and type 2 diabetes
Grip strength often decreases, making it difficult to hold objects firmly
Among the 47.5 million Medicare Part D enrollees in 2023, 9.7 million enrollees met the clinical criteria for the Medicare GLP-1 Bridge in 2023, but less than half of this group3.8 million (39%)is estimated to be eligible for Bridge (Figure 2, Table 1)
Surescripts reported exchanging 30.5 billion health intelligence transactions in 2025 (a 12.3% increase over 2024), and 84% of prescribers now use EHRs equipped with Surescripts Electronic Prior Authorization ( [21] )
some dermatologists recommend 612 months of GLP-1 therapy combined with topical and systemic HS management (antibiotics, biologics like adalimumab, or surgical drainage) for optimal outcomes